Gladigen Overview
- Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
Gladigen General Information
Description
Operator of a biotechnology company specializing in peripheral nerve repair. The company designs, develops and commercializes technology that aligns and seals nerves severed by disease, traumatic events or surgical procedures, overcoming complications from the misdirection and loss of axons.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 4586 South West 48th Way
- Suite 106
- Gainesville, FL 32608
- United States
Gladigen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
Gladigen Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Christopher Gladin Ph.D | Chief Executive Officer |